Gorlin syndrome (nevoid basal cell carcinoma syndrome): Update and literature review

Pediatrics International

Volumn 56, Issue 5, 2014, Pages 667-674

  Fujii, Katsunori ^a   Miyashita, Toshiyuki ^b  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

basal cell carcinoma; Gorlin syndrome; hedgehog signaling; medulloblastoma; PTCH1

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN PATCHED 1; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; SONIDEGIB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI; TRANSCRIPTION FACTOR GLI1 INHIBITOR; UNCLASSIFIED DRUG; VISMODEGIB;

AUTOSOMAL DOMINANT DISORDER; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BRAIN CALCIFICATION; CANCER RESISTANCE; CARDIAC FIBROMA; CHROMOSOME ANALYSIS; CLINICAL FEATURE; DISEASE SURVEILLANCE; DRUG APPROVAL; DRUG EFFICACY; DRUG RESEARCH; DRUG TARGETING; DRUG WITHDRAWAL; ETHNIC DIFFERENCE; EUKARYOTIC FLAGELLUM; EUROPE; FIBROMA; FRAMESHIFT MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; GERMLINE MUTATION; HEART TUMOR; HUMAN; IONIZING RADIATION; JAPAN; MACROCEPHALY; MEDULLOBLASTOMA; MISSENSE MUTATION; MORBIDITY; NONSENSE MUTATION; ODONTOGENIC KERATOCYST; ONSET AGE; OVARY FIBROMA; OVARY TUMOR; PALMAR PIT; PLANTAR PIT; PREVALENCE; PRIORITY JOURNAL; PTCH1 GENE; REVIEW; RIB MALFORMATION; SIGNAL TRANSDUCTION; SKIN MANIFESTATION; TREATMENT RESPONSE; UNITED STATES; UNSPECIFIED SIDE EFFECT; CHILD; GENETICS;

BASAL CELL NEVUS SYNDROME; CHILD; HUMANS;

EID: 84921787774     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12461     Document Type: Review

References (62)

1. Gorlin RJ, Goltz RW,. Multiple nevoid basal-cell epitheliomas, jaw cysts and bifid rib. A syndrome. N. Engl. J. Med. 1960; 262: 908-912.
2. Gorlin RJ,. Nevoid basal cell carcinoma syndrome. Medicine 1987; 66: 98-113.
3. Bree AF, Shah MR, BCNS Colloquium Group. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am. J. Med. Genet. A 2011; 155A: 2091-2097.
4. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841-851.
5. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, candidate gene for the basal cell nevus syndrome. Science 1996; 272: 1668-1671.
6. Satinoff MI, Wells C,. Multiple basal cell naevus syndrome in ancient Egypt. Med. Hist. 1969; 13: 294-297.
7. Evans DG, Howard E, Giblin C, et al. Complications of the naevoid basal cell carcinoma syndrome: Results of a population based study. J. Med. Genet. 1993; 30: 460-464.
8. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM,. Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. Am. J. Med. Genet. A 2010; 152A: 327-332.
9. Shanley S, Ratcliffe J, Hockey A, et al. Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals. Am. J. Med. Genet. 1994; 50: 282-290.
10. Endo M, Fujii K, Sugita K, Saito K, Kohno Y, Miyashita T,. Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low incidence of basal cell carcinoma. Am. J. Med. Genet. A 2012; 158A: 351-357.
11. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am. J. Med. Genet. 1997; 69: 299-308.
12. Gorlin RJ,. Nevoid basal cell carcinoma syndrome. In:, Gomez MR, (ed). Neurocutaneous Diseases. A Practical Approach. Butterworths, Boston, MA, 1987; 67-79.
13. Kimonis VE, Mehta SG, Digiovanna JJ, Bale SJ, Pastakia B,. Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet. Med. 2004; 6: 495-502.
14. Fujita Y, Fujii K, Miyashita T,. Falx cerebri calcification and microphthalmia in Gorlin syndrome. Neurol. Clin. Neurosci. 2013; 1: 88-89.
15. Kimonis VE, Singh KE, Zhong R, Pastakia B, Digiovanna JJ, Bale SJ,. Clinical and radiological features in young individuals with nevoid basal cell carcinoma syndrome. Genet. Med. 2013; 15: 79-83.
16. Lo Muzio L, Nocini P, Bucci P, Pannone G, Consolo U, Procaccini M,. Early diagnosis of nevoid basal cell carcinoma syndrome. J. Am. Dent. Assoc. 1999; 130: 669-674.
17. Morgan TA, Burton CC, Qian F,. A retrospective review of treatment of the odontogenic keratocyst. J. Oral Maxillofac. Surg. 2005; 63: 635-639.
18. Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. International Agency for Research on Cancer Press, Lyon, 2005.
19. Sasaki R, Miyashita T, Saito K, Fujii K, Ando T, Akizuki T,. Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2010; 11: e41-46.
20. Suzuki M, Nagao K, Hatsuse H, et al. Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2013; 116: 348-353.
21. Amlashi SF, Riffaud L, Brassier G, Morandi X,. Nevoid basal cell carcinoma syndrome: Relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 2003; 98: 618-624.
22. Northcott PA, Jones DT, Kool M, et al. Medulloblastomics: The end of the beginning. Nat. Rev. Cancer 2012; 12: 818-834.
23. Gorlin RJ,. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet. Med. 2004; 6: 530-539.
24. Lindström E, Shimokawa T, Toftgård R, Zaphiropoulos PG,. PTCH mutations: Distribution and analyses. Hum. Mutat. 2006; 27: 215-219.
25. Fujii K, Kohno Y, Sugita K, et al. Mutations in the human homologue of Drosophila patched in Japanese nevoid basal cell carcinoma syndrome patients. Hum. Mutat. 2003; 21: 451-452.
26. Fujii K, Miyashita T, Takanashi J, et al. Gamma-irradiation deregulates cell cycle control and apoptosis in nevoid basal cell carcinoma syndrome-derived cells. Jpn. J. Cancer Res. 1999; 90: 1351-1357.
27. Minami M, Urano Y, Ishigami T, Tsuda H, Kusaka J, Arase S,. Germline mutations of the PTCH gene in Japanese patients with nevoid basal cell carcinoma syndrome. J. Dermatol. Sci. 2001; 27: 21-26.
28. Fujii K, Miyashita T, Omata T, et al. Gorlin syndrome with ulcerative colitis in a Japanese girl. Am. J. Med. Genet. A 2003; 121: 65-68.
29. Nagao K, Fujii K, Yamada M, Miyashita T,. Identification of a novel polymorphism involving a CGG repeat in the PTCH gene and a genome-wide screening of CGG-containing genes. J. Hum. Genet. 2004; 49: 97-101.
30. Nagao K, Togawa N, Fujii K, et al. Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays. Hum. Mol. Genet. 2005; 14: 3379-3388.
31. Nagao K, Toyoda M, Takeuchi-Inoue K, Fujii K, Yamada M, Miyashita T,. Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons. Genomics 2005; 85: 462-471.
32. Fujii K, Ishikawa S, Uchikawa H, et al. High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome. Hum. Genet. 2007; 122: 459-466.
33. Unden AB, Holmberg E, Lundh-Rozell B, et al. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: Different in vivo mechanisms of PTCH inactivation. Cancer Res. 1996; 56: 4562-4565.
34. Tachi N, Fujii K, Kimura M, Seki K, Hirakai M, Miyashita T,. A new mutation of the PTCH gene in a patient with nevoid basal cell carcinoma syndrome associated with West syndrome. Pediatr. Neurol. 2007; 37: 363-365.
35. Sasaki R, Saito K, Watanabe Y, et al. Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations. J. Hum. Genet. 2009; 54: 398-402.
36. Nagao K, Fujii K, Saito K, et al. Entire PTCH1 deletion is a common event in point mutation-negative cases with nevoid basal cell carcinoma syndrome in Japan. Clin. Genet. 2011; 79: 196-198.
37. Kosaki R, Nagao K, Kameyama K, Suzuki M, Fujii K, Miyashita T,. Heterozygous tandem duplication within the PTCH1 gene results in nevoid basal cell carcinoma syndrome. Am. J. Med. Genet. 2012; 158A: 1724-1728.
38. Suzuki M, Hatsuse H, Nagao K, et al. Selective haploinsufficiency of longer isoforms of PTCH1 protein can cause nevoid basal cell carcinoma syndrome. J. Hum. Genet. 2012; 57: 422-426.
39. Pastorino L, Ghiorzo P, Nasti S, et al. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am. J. Med. Genet. A 2009; 149A: 1539-1543.
40. Kijima C, Miyashita T, Suzuki M, Oka H, Fujii K,. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Fam. Cancer 2012; 11: 565-570.
41. Fan Z, Li J, Du J, et al. A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family. J. Med. Genet. 2008; 45: 303-308.
42. Fujii K, Ohashi H, Suzuki M, et al. Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome. Fam. Cancer 2013; 12: 611-614.
43. O'Malley S, Weitman D, Olding M, Sekhar L,. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report. J. Neurosurg. 1997; 86: 286-288.
44. Atahan IL, Yildiz F, Ozyar E, Uzal D, Zorlu F,. Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome. Pediatr. Hematol. Oncol. 1998; 15: 187-191.
45. Campbell RM, Mader RD, Dufresne RG Jr,. Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndrome. J. Am. Acad. Dermatol. 2005; 53: S256-259.
46. Elejalde BR,. In-vitro transformation of cells from patients with naevoid basal-cell carcinoma syndrome. Lancet 1976; 2: 1199-1200.
47. Ringborg U, Lambert B, Landergen J, Lewensohn R,. Decreased UV-induced DNA repair synthesis in peripheral leukocytes from patients with nevoid basal cell carcinoma syndrome. J. Invest. Dermatol. 1981; 76: 268-270.
48. Nagasawa H, Little FF, Burke MJ, et al. Study of basal cell nevus syndrome fibroblasts after treatment with DNA damaging agents. Basic Life Sci. 1984; 29B: 775-785.
49. Fetherstone T, Taylor AMR, Harnden DG,. Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome. Am. J. Hum. Genet. 1983; 35: 58-66.
50. Barnes EA, Kong M, Ollendorff V, Donoghue DJ,. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 2001; 20: 2214-2223.
51. Fujii K, Suzuki N, Ishijima S, et al. Abnormal DNA synthesis activity induced by X-rays in nevoid basal cell carcinoma syndrome cells. Biochem. Biophys. Res. Commun. 1997; 240: 269-272.
52. Dezawa M, Fujii K, Kita K, et al. Increase in nucleoli after x-radiation of fibroblasts of patients with Gorlin syndrome. J. Lab. Clin. Med. 1999; 134: 585-591.
53. Goetz SC, Anderson KV,. The primary cilium: A signalling centre during vertebrate development. Nat. Rev. Genet. 2011; 111: 331-344.
54. Singla V, Reiter JF,. The primary cilium as the cell's antenna: Signaling at a sensory organelle. Science 2006; 313: 629-633.
55. Huangfu D, Liu A, Rakeman AS, et al. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 2003; 426: 83-87.
56. Rohatgi R, Milenkovic L, Scott MP,. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007; 317: 372-376.
57. Amakye D, Jagani Z, Dorsch M,. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med. 2013; 19: 1410-1422.
58. Rudin CM,. Vismodegib. Clin. Cancer Res. 2012; 18: 3218-3222.
59. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 2009; 361: 1164-1172.
60. Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 2009; 361: 1173-1178.
61. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N. Engl. J. Med. 2012; 366: 2180-2188.
62. Yauch RL, Dijkgraaf GJ, Alicke B, et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009; 326: 572-574.